Research - Bengaluru, Karnataka, India
Current cell and gene therapy products are estimated to cost >$250k per injection. This is unsustainable.Our vision is to democratize access to cell therapy and provide benefits to a larger section of humanityWe intend to disrupt the global cell therapy ecosystem and set a new benchmark for quality and affordability in this sector.Eyecyte-RPE-our flagship project to treat incurable macular degeneration has excellent efficacy results and will be in FIM trials in 2021.
Apache
WordPress.org
Google Tag Manager
GoDaddy Hosting
Bootstrap Framework
Mobile Friendly